Published in J Immunol on February 27, 2012
Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers. J Immunol (2013) 0.84
Neonatal Fc receptor promotes immune complex-mediated glomerular disease. J Am Soc Nephrol (2013) 0.84
Mouse models of membranous nephropathy: the road less travelled by. Am J Clin Exp Immunol (2013) 0.80
Quaternary epitopes of α345(IV) collagen initiate Alport post-transplant anti-GBM nephritis. J Am Soc Nephrol (2013) 0.79
Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy. Front Immunol (2016) 0.77
Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes. Am J Physiol Renal Physiol (2016) 0.75
Basement membranes and autoimmune diseases. Matrix Biol (2016) 0.75
Interstitial mononuclear infiltrates in murine α3(IV)-NC1-induced nephropathy: harbingers of renal failure? Kidney Int (2012) 0.75
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81
Fcgamma receptors: old friends and new family members. Immunity (2006) 5.60
Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med (2003) 4.77
Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96
Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med (2010) 3.78
Deficiency of the fifth component of complement in mice with an inherited complement defect. J Exp Med (1967) 3.28
Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med (2011) 3.17
Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med (2002) 3.15
Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science (1998) 2.95
Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol (2010) 2.22
Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem (1988) 2.21
Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest (1982) 2.12
Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med (2006) 2.00
Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. J Clin Invest (1998) 1.88
Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network. J Am Soc Nephrol (2008) 1.81
Cellular response to injury in membranous nephropathy. J Am Soc Nephrol (2005) 1.77
Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. J Exp Med (2000) 1.75
Type IV collagen of the glomerular basement membrane. Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J Biol Chem (2000) 1.73
Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen. J Am Soc Nephrol (2005) 1.69
Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome. Am J Pathol (2002) 1.67
Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int (2005) 1.61
The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis (2010) 1.60
Cellular origins of type IV collagen networks in developing glomeruli. J Am Soc Nephrol (2009) 1.59
Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int (1999) 1.55
Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol (2009) 1.55
Experimental membranous nephropathy redux. Am J Physiol Renal Physiol (2005) 1.52
Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol (2008) 1.39
Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J Exp Med (2000) 1.39
The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain. J Biol Chem (1999) 1.37
Membranous nephropathy: an IgG4-mediated disease. Lancet (1998) 1.36
Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis. J Biol Chem (2005) 1.35
Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice. J Am Soc Nephrol (2006) 1.35
Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol (2004) 1.34
Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies. J Biol Chem (1999) 1.33
The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem (2000) 1.27
Membranous nephropathy with crescents. J Am Soc Nephrol (2011) 1.25
The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. FASEB J (2003) 1.25
Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3. J Biol Chem (2006) 1.20
Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol (2005) 1.19
Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol (2005) 1.18
A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes. J Biol Chem (2008) 1.17
A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice. Am J Pathol (2003) 1.14
Autoepitopes and alloepitopes of type IV collagen: role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis. Nephron Exp Nephrol (2007) 1.05
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J Immunol (2008) 1.04
Controversies in the treatment of idiopathic membranous nephropathy. Nat Rev Nephrol (2009) 1.02
The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum? Am J Kidney Dis (2004) 1.01
Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficient mice. Eur J Immunol (2000) 1.00
Experimental Models of Membranous Nephropathy. Drug Discov Today Dis Models (2010) 1.00
Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice. Arthritis Rheum (2003) 0.99
Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. J Clin Invest (2009) 0.96
The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain. J Biol Chem (2007) 0.94
Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation (2000) 0.94
Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int (1998) 0.93
Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. Nephrol Dial Transplant (2004) 0.93
Both Fcgamma receptor I and Fcgamma receptor III mediate disease in accelerated nephrotoxic nephritis. Am J Pathol (2003) 0.92
Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol (2005) 0.92
Nephritogenicity of proteoglycans. II. A model of immune complex nephritis. Kidney Int (1988) 0.92
Alport alloantibodies but not Goodpasture autoantibodies induce murine glomerulonephritis: protection by quinary crosslinks locking cryptic α3(IV) collagen autoepitopes in vivo. J Immunol (2010) 0.91
Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis. J Immunol (2011) 0.89
Augmented expression of glomerular basement membrane specific type IV collagen isoforms (alpha3-alpha5) in experimental membranous nephropathy. Proc Assoc Am Physicians (1998) 0.88
Predominant role of FcgammaRIII in the induction of accelerated nephrotoxic glomerulonephritis. Kidney Int (2003) 0.88
Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis. Nephron (2002) 0.87
Evidence for a role of antilaminin-producing B cell clones that escape tolerance in the pathogenesis of HgCl2-induced membranous glomerulopathy. Nephrol Dial Transplant (1993) 0.85
Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy. Kidney Int (2007) 0.84
Differential expression of basement membrane collagen in membranous nephropathy. Am J Pathol (1991) 0.84
Immune-complex nephritis in the rabbit produced by injections of rat renal tubular fraction 3 antigen. Br J Exp Pathol (1981) 0.84
Deletion of activating Fcgamma receptors does not confer protection in murine cryoglobulinemia-associated membranoproliferative glomerulonephritis. Am J Pathol (2009) 0.79
The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38
The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 4.77
Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis (2004) 4.20
Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med (2010) 3.78
Pathologic classification of diabetic nephropathy. J Am Soc Nephrol (2010) 3.61
Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol (2006) 3.19
Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol (2003) 3.06
C3 glomerulopathy: consensus report. Kidney Int (2013) 2.85
Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res (2002) 2.69
Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes (2005) 2.67
Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol (2012) 2.42
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int (2011) 2.34
Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol (2005) 2.33
Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. J Am Coll Cardiol (2012) 2.21
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int (2010) 2.14
Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. Am J Pathol (2003) 2.05
Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals. Cell (2007) 2.00
Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation (2002) 1.96
Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int (2003) 1.94
Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol (2005) 1.94
Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest (2010) 1.90
Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations. Kidney Int (2012) 1.87
Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes (2004) 1.85
Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol (2004) 1.85
Irradiation prolongs survival of Alport mice. J Am Soc Nephrol (2008) 1.84
Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol (2006) 1.82
Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res (2010) 1.82
Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice. Circ Res (2007) 1.81
Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network. J Am Soc Nephrol (2008) 1.81
Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol (2002) 1.79
Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells (2012) 1.78
Podocyte injury damages other podocytes. J Am Soc Nephrol (2011) 1.75
Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int (2002) 1.69
Large-scale identification of genes implicated in kidney glomerulus development and function. EMBO J (2006) 1.69
Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen. J Am Soc Nephrol (2005) 1.69
Dystroglycan in the diagnosis of FSGS. Clin J Am Soc Nephrol (2009) 1.60
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney Int (2012) 1.60
Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev Biol (2008) 1.59
Cellular origins of type IV collagen networks in developing glomeruli. J Am Soc Nephrol (2009) 1.59
Generation of a transplantable erythropoietin-producer derived from human mesenchymal stem cells. Transplantation (2008) 1.58
Renal biopsy findings among Indigenous Australians: a nationwide review. Kidney Int (2012) 1.56
Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol (2008) 1.56
Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol (2009) 1.55
Unexplained nephrotic-range proteinuria in a 38-year-old man: a case of "no change disease". Am J Kidney Dis (2004) 1.54
Type IV collagen induces podocytic features in bone marrow stromal stem cells in vitro. J Am Soc Nephrol (2005) 1.53
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res (2009) 1.53
Validation of the Oxford classification of IgA nephropathy. Kidney Int (2011) 1.53
Complement deficiency ameliorates collagen-induced arthritis in mice. J Immunol (2002) 1.51
Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin. J Clin Invest (2016) 1.49
Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am J Physiol Renal Physiol (2007) 1.46
Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest (2002) 1.45
Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling. Arterioscler Thromb Vasc Biol (2004) 1.44
Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol (2005) 1.44
Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int (2005) 1.42
Sensorineural deafness and male infertility: a contiguous gene deletion syndrome. J Med Genet (2006) 1.36
COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int (2002) 1.35
Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis. J Biol Chem (2005) 1.35
HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J Am Soc Nephrol (2006) 1.35
Mouse model of X-linked Alport syndrome. J Am Soc Nephrol (2004) 1.35
Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice. J Am Soc Nephrol (2006) 1.35
Dominant mutations of Col4a1 result in basement membrane defects which lead to anterior segment dysgenesis and glomerulopathy. Hum Mol Genet (2005) 1.33
Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury. Am J Pathol (2004) 1.33
The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J Clin Invest (2002) 1.32
Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB. Eur J Immunol (2003) 1.32
Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains. J Biol Chem (2002) 1.32
Regression of existing glomerulosclerosis by inhibition of aldosterone. J Am Soc Nephrol (2005) 1.31
Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease. Pediatrics (2004) 1.31
Transcriptome-based systematic identification of extracellular matrix proteins. Proc Natl Acad Sci U S A (2008) 1.31
Cell senescence in the aging kidney. J Am Soc Nephrol (2010) 1.30
Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol (2005) 1.28
Pathology of human diabetic nephropathy. Contrib Nephrol (2011) 1.26
Membranous nephropathy with crescents. J Am Soc Nephrol (2011) 1.25
Compositional differences between infant and adult human corneal basement membranes. Invest Ophthalmol Vis Sci (2007) 1.25
Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. J Clin Invest (2014) 1.24
Models of chronic kidney disease. Drug Discov Today Dis Models (2010) 1.24
The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. J Am Soc Nephrol (2009) 1.22
AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke (2006) 1.22
Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis (2005) 1.22
Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3. J Biol Chem (2006) 1.20
High nephritogenicity of monoclonal antibodies belonging to IgG2a and IgG2b subclasses in rat anti-GBM nephritis. Kidney Int (2004) 1.20
Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis? Clin J Am Soc Nephrol (2012) 1.18
Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol (2012) 1.17
A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes. J Biol Chem (2008) 1.17
Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt. Kidney Int (2009) 1.17
Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease. Kidney Int (2005) 1.17
Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria. J Am Soc Nephrol (2002) 1.16
Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. Hum Mutat (2012) 1.15
DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria. Kidney Int (2004) 1.15
Expression of FcgammaRIII is required for development of collagen-induced arthritis. Eur J Immunol (2002) 1.14
A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice. Am J Pathol (2003) 1.14
Two novel GALNT3 mutations in familial tumoral calcinosis. Am J Med Genet A (2007) 1.14
An autosomal recessive syndrome of severe mental retardation, cataract, coloboma and kyphosis maps to the pericentromeric region of chromosome 4. Eur J Hum Genet (2008) 1.14